<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Rendas-Baum R</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To identify key non-motor symptoms of Parkinson's disease (PD) to include in a daily diary assessment for off-time, revise the Scales for Outcomes of Parkinson's disease Diary Card (SCOPA-DC) to include these non-motor symptoms, and investigate the validity, reliability and predictive utility of the Revised SCOPA-DC in a U.S. population.&lt;h4>Methods&lt;/h4>A convenience sample was used to recruit four focus groups of PD patients. Based on findings from focus groups, the SCOPA-DC was revised and administered to a sample of 101 PD patients. Confirmatory factor analysis was conducted to test the domain structure of the Revised SCOPA-DC. The reliability, convergent and discriminant validity, and ability to predict off-time of the Revised SCOPA-DC were then assessed.&lt;h4>Results&lt;/</pubmed_abstract><journal>Health and quality of life outcomes</journal><pagination>69</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3173285</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinson's disease.</pubmed_title><pmcid>PMC3173285</pmcid><pubmed_authors>Buck PO</pubmed_authors><pubmed_authors>Rendas-Baum R</pubmed_authors><pubmed_authors>White MK</pubmed_authors><pubmed_authors>Castelli-Haley J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinson's disease.</name><description>&lt;h4>Background&lt;/h4>To identify key non-motor symptoms of Parkinson's disease (PD) to include in a daily diary assessment for off-time, revise the Scales for Outcomes of Parkinson's disease Diary Card (SCOPA-DC) to include these non-motor symptoms, and investigate the validity, reliability and predictive utility of the Revised SCOPA-DC in a U.S. population.&lt;h4>Methods&lt;/h4>A convenience sample was used to recruit four focus groups of PD patients. Based on findings from focus groups, the SCOPA-DC was revised and administered to a sample of 101 PD patients. Confirmatory factor analysis was conducted to test the domain structure of the Revised SCOPA-DC. The reliability, convergent and discriminant validity, and ability to predict off-time of the Revised SCOPA-DC were then assessed.&lt;h4>Results&lt;/</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Aug</publication><modification>2026-05-15T03:13:36.705Z</modification><creation>2019-03-27T00:43:57Z</creation></dates><accession>S-EPMC3173285</accession><cross_references><pubmed>21851616</pubmed><doi>10.1186/1477-7525-9-69</doi></cross_references></HashMap>